|Title:||Treating conjunctivitis by topically administering an epinastine solution to the conjunctiva|
|Abstract:||Treating allergic conjunctivitis by administered aqueous solutions containing epinastine, optionally in the form of its racemate or its enantiomers and optionally, in the form of the pharmacologically acceptable acid addition salts thereof, to the conjunctiva.|
|Inventor(s):||Trach; Volker (Biberach, DE), Duschler; Gerold (Ehingen, DE)|
|Assignee:||Boehringer Ingelheim Pharma GmbH & Co. Kg (Ingelheim, DE)|
Patent Claim Types:|
see list of patent claims
Back Citations: 4th percentile
Forward Citations: 0th percentile
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|Germany||199 54 516||Nov 12, 1999|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.